Post by
longterm56 on Apr 12, 2021 7:42am
Nothing
A big yawn in pre-market trading. Another great achievement by the IR people. Not just anytime can keep the share price smothered after such great news. Truly amazing.
Comment by
Lee430 on Apr 12, 2021 8:22am
You would think for Thera to invest in a top tier IR firms services to fix this must be much less expensive than a depressed share price.
Comment by
PinnacleX on Apr 12, 2021 2:03pm
Bizarre is an understatment, its unheard of. This should be double on that news alone, WTF a tumor gone using your treatment in 21 days!!!! and NOTHING! what makes it even more so its on the NYSE and it doesnt get picked up there aswell.
Comment by
qwerty22 on Apr 12, 2021 3:43pm
Nope, the oddest thing was the 50% rise last year. This years AACR data is not worth $450 million.
Comment by
qwerty22 on Apr 12, 2021 3:52pm
So we're heading for a 4% rise and Xbi is again down 1.5-2%. I'm not hating today's reaction.
Comment by
Lee430 on Apr 12, 2021 6:25pm
qwerty22, Thank you for the sanity check today, it was much appeciated......except for realitycheck4u I think most of us were disapointed with todays reaction, sooooo back to waiting for the next catalyst.
Comment by
Wino115 on Apr 12, 2021 7:57pm
Clinical data for cancer will be a step-function kind of catalyst if positive (or negative). It will also really help their ability to pitch a convincing story. It's all reinforcing each other.
Comment by
palinc2000 on Apr 12, 2021 9:04pm
The stock has really made a nice comeback and the upward momentum still intact .... Breaking thru 4 US and 5 Cad will add speed to the momentum.... Decent revenue growth in the first Quarter and maybe at last positive revenue guidance for the remainder of the FY would also keep the momentum intact .... Any good news on the pipeline will of course be icing on the cake in the short term
Comment by
JayjayUSA12007 on Apr 12, 2021 9:30pm
Or it could simply be an announcement of (1) partnership in NASH or oncology programs. (2) out-licensing of some anti-cancer indications, or NASH
Comment by
FredTheVoice on Apr 13, 2021 5:24am
You are right JAY, The shares wont skyrock without clarification on the NASH front, I dont think even decent numbers around sales will change that at this point. Some institutions are waiting to buy more for a company in phase III in NASH, but OFFICIALLY IN PHASE III, not with only the big toe in it.... Lets see. FTV.